Phase 2 data demonstrate differentiated CXCR4 inhibition kinetics enabling same-day cell collection, with rapid lymphocyte mobilization supporting potential therapeutic applications beyond transplant ...
A new finger prick test claims to detect Alzheimer’s with 91% accuracy using p-tau217 biomarkers. Learn how this accessible ...
Our team at the UK Dementia Research Institute’s Biomarker Factory at UCL are part of the global effort working to develop ...
Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies73% ...
A report that was jointly produced by the Canadian Centre for Policy Alternatives and the Parkland Institute finds Alberta's ...
The State of Trust Report by Vanta, which surveyed IT and business leaders in the U.S., U.K., and Australia in July 2025, ...
The idea of diagnosing Alzheimer’s with a quick, finger-prick test marks a profound shift in how we could approach ...
TikTok's new terms (22 Jan 2026) alarm users with a pop-up on data collection, revealing it may gather sensitive info like ...
Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that it will present a poster at the upcoming 2026 Tandem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results